It has been demonstrated that CD74 is implicated in regulating drug resistance across various cancers, including non-small cell lung cancer[38]and gliomas,[39] where its genetic fusion with ROS1 is prevalent. The gene discussed is CD74; the disease is non-small cell lung carcinoma.